Active Health Foods, Inc. (OTCPK:AHFD) agreed to acquire 100% stake in Bioidentical Hormones Inc. on June 8, 2022. Active Health acquired Bioidentical and its principal subsidiary, Australian Menopause Centre. In a separate transaction, Active Health has been approved by the Securities and Exchange Commission to commence a $20 million Regulation A public offering at $0.001 per share for 20 billion shares.

Investors will receive a total of 10% of the Company, fully diluted, for $20 million, valuing the Company at $200 million.